Table 3.
Demographic and biochemical data of CAAG patients with and without vitamin D deficiency
| Patients | 25(OH)D deficiency (n = 57) | Normal 25(OH)D (n = 30) | p value |
|---|---|---|---|
| Female n (%) | 47 (83) | 24 (80) | ns |
| Age (years) Mean ± SD |
63.4 ± 12.8 | 64.6 ± 12.9 | ns |
| APCA positivity n (%) |
50 (88) | 29 (97) | ns |
| Atrophy n (%) | |||
| • mild | 24 (42) | 13 (43) | ns |
| • moderate | 20 (35) | 14 (47) | |
| • severe | 13 (23) | 3 (10) | |
| ECL cell hyperplasia n (%) | |||
| • normal | 17 (30) | 7 (23) | ns |
| • linear | 12 (21) | 11 (37) | |
| • micronodular | 10 (17) | 7 (23) | |
| • gastric carcinoid | 18 (32) | 5 (17) | |
APCA Anti-parietal cell antibodies, ECL entero-chromaffin-like, 25(OH)D 25-OH-Vitamin D